dragon

Azerbaijan Medical Journal

Scopus Indexed (2026)

Scopus Indexed Journal & Country Rank

SJR (2026)

Scimago Journal & Country Rank
Aim and Scope

Azerbaijan Medical Journal

The Azerbaijan Medical Journal (AMJ) is a peer-reviewed, open-access monthly publication dedicated to advancing medical science and clinical practice through the dissemination of high-quality, original research. The Journal aims to serve as a global platform for researchers, clinicians, and healthcare professionals to share innovative findings, critical reviews, and evidence-based insights that contribute to the understanding, prevention, diagnosis, and treatment of diseases.

AMJ welcomes submissions across a broad spectrum of medical disciplines, including but not limited to:

  • • Internal Medicine and its subspecialties
  • • Surgery and surgical innovations
  • • Pediatrics and neonatology
  • • Obstetrics, gynecology, and reproductive health
  • • Public health, epidemiology, and global health
  • • Medical education and health policy
  • • Pharmacology and therapeutics
  • • Diagnostic imaging and laboratory medicine
  • • Emerging infectious diseases and pandemic preparedness
  • • Translational and interdisciplinary medical research
  • • Dental health

The Journal particularly encourages contributions from early-career researchers, multidisciplinary teams, and authors from underrepresented regions. All manuscripts undergo rigorous double-blind peer review to ensure scientific integrity, methodological soundness, and relevance to contemporary medical challenges.We invite authors worldwide to submit original articles, review papers, case reports, brief communications, and study protocols that align with the Journal’s mission of promoting excellence, equity, and accessibility in medical scholarship.

📝 Official Submission Process

Manuscripts must be submitted officially through our online system. Please complete the REGISTRATION FORM on our website first to access your Author Dashboard. You may then submit your manuscript for an initial review by our dedicated editorial team to assess its compliance with our journal's policies and scope.

Step-by-Step Submission Process:
  1. 1. Complete registration Form
  2. 2. Access Your Applicant Dashboard
  3. 3. Submit a new article
  4. 4. Fill Out the Submission Form.
    Please ensure you provide a title and abstract for your article, and upload the required document files.
    Accepted formats are PDF, TXT, and DOCX (up to 10MB per file). You may upload up to 5 files.
    The first document file is mandatory.
💡 Need Help?

For technical assistance with submission or registration, please contact:

For general editorial questions or policy inquiries:

Latest Articles

Azerbaijan Medical Journal

AMJ-11-08-2025-12326
Study of laboratory parameters after hemodialysis for patients with chronic renal disease in Syrian patient

Author(s): Seraj mresh, Suzanne Alshimali, Remal Abdulaziz Asaad

Abstract: Background: Hemodialysis may elicit a series of changes in blood cells upon patients suffering from chronic kidney disease(CKD). Objective: The aim of this study was to evaluate the effects of hemodialysis on hematologic components and coagulation systems in CKD patients. Patients and Methods: A prospective study(Before&After) conducted in 70 patients with a diagnosis of CKD who underwent hemodialysis. They were selected from department of Nephrology, Tishreen University Hospital in...
Read More Azerbaijan Medical Journal • 11-08-2025
AMJ-11-08-2025-12325
Advanced Dental Care Management for Patients with Systemic Diseases: An Integrated Perspective for Enhanced Treatment Outcomes

Author(s): Nour .B.Hasan

Abstract: Dental care for patients with systemic diseases is a complex process that requires a precise, integrated approach that surpasses routine clinical practices. With the notable increase in the number of individuals living longer with chronic medical conditions, it becomes essential for dental practitioners to perform comprehensive risk assessments and adjust treatment protocols according to the patient’s overall health status, ensuring maximum safety and achieving stable therapeutic outcome...
Read More Azerbaijan Medical Journal • 11-08-2025
AMJ-21-07-2025-12324
CRISPR-Cas9 Epigenetic Reprogramming of Microglia: A Novel Therapeutic Strategy for Alzheimer's Disease Modulation

Author(s): Dr. Sarah Chen, Dr. James Al-Khatib, Dr. Maria Rodriguez

Abstract: Alzheimer's disease (AD) pathogenesis is increasingly linked to microglial dysfunction and neuroinflammation. While genetic editing approaches have shown promise, epigenetic modulation of microglial phenotype transitions remains unexplored. This study introduces a novel CRISPR-dCas9-based epigenetic editing platform targeting the TREM2 and CX3CR1 loci to induce M2-like anti-inflammatory microglial states in APP/PS1 transgenic mice. Using adeno associated virus serotype 9 (AAV9) delivery v...
Read More Azerbaijan Medical Journal • 21-07-2025
AMJ-21-07-2025-12323
Engineered Exosomes Derived from Hypoxic Mesenchymal Stem Cells: Enhanced Blood-Brain Barrier Penetration for Glioblastoma Targeting

Author(s): Dr. Ahmed Hassan, Dr. Lisa Park

Abstract: Glioblastoma multiforme (GBM) treatment is hindered by the impermeable blood-brain barrier (BBB) and poor drug bioavailability. This study characterizes exosomes isolated from mesenchymal stem cells (MSCs) cultured under 1% O₂ hypoxic conditions and evaluates their BBB transcytosis capabilities. Hypoxic preconditioning significantly enriched exosomal cargo with miR-126 and matrix metalloproteinase-9 (MMP-9), facilitating tight junction modulation in human brain microvascular endothelial ...
Read More Azerbaijan Medical Journal • 21-07-2025
AMJ-17-06-2025-12322
Circulating Cell-Free DNA Methylation Signatures as Multi-Cancer Early Detection Biomarkers: A Machine Learning-Integrated Liquid Biopsy Platform

Author(s): Dr. Robert Kim, Dr. Fatima Al-Rashid, Dr. David Okafor

Abstract: Early detection of malignancies remains the cornerstone of improving oncologic outcomes. We developed a comprehensive cell-free DNA (cfDNA) methylation profiling assay coupled with deep neural network architecture (CancerGuard-AI) capable of simultaneous detection and tissue-of-origin localization across 12 solid tumor types. Analyzing 2,500 plasma samples from stage I-III cancer patients and healthy controls, our platform achieved 94.3% sensitivity at 98.1% specificity, outperforming ex...
Read More Azerbaijan Medical Journal • 17-06-2025
dragon